Press Releases April 22, 2026 04:05 PM

BBSI Sets First Quarter 2026 Conference Call for Wednesday, May 6, 2026, at 5:00 p.m. ET

BBSI to announce Q1 2026 earnings on May 6 with CEO and CFO conference call

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
BBSI

Barrett Business Services, Inc., a leading U.S. professional employer organization (PEO), will report its financial results for the first quarter ended March 31, 2026, on May 6. The company has scheduled a conference call hosted by its CEO and CFO to discuss the results and answer investor questions.

BBSI Sets First Quarter 2026 Conference Call for Wednesday, May 6, 2026, at 5:00 p.m. ET
BBSI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • BBSI will release Q1 2026 financial results followed by a conference call on May 6, 2026.
  • The company operates as a PEO providing HR outsourcing, payroll, workers’ compensation, and risk management services across all 50 states.
  • BBSI works with over 8,200 PEO clients and uses an integrated business management platform to differentiate itself from competitors.

VANCOUVER, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., will conduct a conference call on Wednesday, May 6, 2026, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the first quarter ended March 31, 2026. The company will report its financial results in a press release prior to the conference call.

BBSI’s CEO Gary Kramer and CFO Anthony Harris will host the conference call, followed by a question and answer period.

Date: Wednesday, May 6, 2026
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in number: 1-800-717-1738
International dial-in number: 1-646-307-1865
Conference ID: 11161330

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

The conference call will be broadcast live and available for replay here and via the Investors section of the BBSI website at ir.bbsi.com.

A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through June 6, 2026.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 11161330

About BBSI

BBSI (NASDAQ: BBSI) is a leading provider of business management solutions, combining human resource outsourcing and professional management consulting to create a unique operational platform that differentiates it from competitors. The company’s integrated platform is built upon expertise in payroll processing, employee benefits, workers’ compensation coverage, risk management and workplace safety programs, and human resource administration. BBSI’s partnerships help businesses of all sizes improve the efficiency of their operations. The company works with more than 8,200 PEO clients in all 50 states. For more information, please visit www.bbsi.com.

Investor Relations:

Gateway Group, Inc.
Cody Slach
Tel 1-949-574-3860
[email protected]


Risks

  • Financial performance could be impacted by changes in labor market conditions affecting demand for PEO services.
  • Regulatory changes impacting HR outsourcing, workers' compensation, or payroll processing might affect BBSI's operations.
  • Competition within the business management solutions and PEO sector could pressure margins or market share.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026